BioPortfolio

Download detailed PDF PDF Version
Email profile changes
Upgrade this profile
Add a new company

T2C2 (Technology, Transfer, Commercialisation, Capital) has the mission to identify in Universities, Research Centres and Industry, business opportunities and turn them into real businesses. Outstanding science, high-quality entrepreneurs, intellectual property and commercial potential are the key elements and criteria that are used to select projects. T2C2 gets involved in the seed phase to support the continuation of the research and to develop the business engineering of the project. Following the seed phase, T2C2 participates with other investors in the financing of the following rounds.

Contact Details:
	1550 Metcalfe Street, Suite 502
	Montréal
	Quebec
	H3A 1X6
	Canada
Tel:	(514) 842-9849
Fax:	(514) 842-1505
Email:	dletendre@t2c2capital.com
WWW:	www.t2c2capital.com/

Press Releases on T2C2:
Cytheris launches two new Phase I clinical trials for its recombinant	1st January, 1970	Cytheris	Cytheris launches two new Phase I clinical trials for its recombinant Interleukin-7 Studies in US and France target immunodeficiency in HIV infected patients
Cytheris launches a new Phase I clinical trial in the US for its	1st January, 1970	Cytheris	Cytheris launches a new Phase I clinical trial in the US for its recombinant Interleukin-7 Study in the Memorial Sloan Kettering Cancer Center targets

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 333 times since April 2007, the link to the organisation's website has been followed 68 times

Search for more companies in Montréal

Search for more companies in Quebec

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for T2C2

T2C2

Press Releases on T2C2: